Applying Classification of Recommendation and Level of Evidence

Slides:



Advertisements
Similar presentations
Natural history of Aortic stenosis
Advertisements

STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.
© Continuing Medical Implementation …...bridging the care gap Valvular Heart Disease Aortic Stenosis.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
Asymptomatic Aortic Stenosis and Exercise Test
Long-Term Outcomes Using a Self- Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery: Two-Year Results From.
Preliminary results from the C-Pulse OPTIONS HF European Multicenter Post-Market Study Holger Hotz, CardioCentrum Berlin, Berlin, Germany; Antonia Schulz,
Valvular heart surgery in Rajavithi hospital Dr.WITTAWAT PIBUL Rajavithi Hospital.
Valvular Heart Disease. Normal heart valves function to maintain the direction of blood flow through the atria and ventricles to the rest of the body.
Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2007 ACC/AHA and 2009 ESC GUIDELINES.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 40 Nursing Care of the Child with a Cardiovascular Disorder.
Valvular Heart DISEASE
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
AATS Annual Meeting 2015 | Seattle, WA | April 27, 2015 Appropriate Patient Selection or Healthcare Rationing? Lessons from Surgical Aortic Valve Replacement.
New guidelines for CABG
A shifting paradigm of care: Advances in transcatheter heart valve procedures Sandra Lauck MSN, RN, CCN(C) Clinical Nurse Specialist, Arrhythmia Management.
Adult Medical-Surgical Nursing
Surgical outcome of native valve infective endocarditis in srinagarind hospital
Transcather Aortic Valve Replacement Using the Self-Expanding Bioprosthesis: First Report Using STS/ACC Transcatheter Valve Therapy Registry CoreValve.
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
ACC/AHA 2006 guidelines on the management of PAD.
Trancatheter Aortic Valve Implantation (TAVI)
Heart Failure Devices: Staying Connected Lisa D. Rathman, MSN, CRNP, CCRN, CHFN The Heart Group of Lancaster General Health Lancaster, PA.
Pathophysiology BMS 243 Rheumatic Heart Disease
Greater New York Geriatric Cardiology Consortium: Valve Disease in Older Adults Allan Schwartz, MD Columbia University Medical Center New York Presbyterian.
© free-ppt-templates.com 2017 AHA/ACC Focused Update of Valvular Heart Disease Guideline of 2014 DR. OMAR SHAHID TR CARDIOLOGY SZH.
Carotid Access for TAVR: An underappreciated approach?
Management of Hypertension according to JNC 7
Outcomes in the CoreValve US High-Risk Pivotal Trial in Patients with a Society of Thoracic Surgeons Predicted Risk of Mortality Less than or Equal to.
Patients at intermediate surgical risk undergoing isolated interventional or surgical aortic valve replacement for severe symptomatic aortic valve stenosis.
Cardiac Rehabilitation Part I
Extending the Boundaries of TAVR: Future Directions
Copyright © 2012 American Medical Association. All rights reserved.
Raj R. Makkar, MD On behalf of The PARTNER Trial Investigators
Are we ready to perform TAVI in Intermediate Risk Patients?
Predictors of Rehospitalization Following Transcatheter Aortic Valve Replacement: Results from the CoreValve US Trial Program James B. Hermiller Jr, MD,
Obstructive Hypertrophic Cardiomyopathy
Lako S, Daka A, Nurka T, Dedej T, Memishaj S
Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients with Aortic Stenosis Description: The goal of the trial was to assess.
TAVR – The Trans-carotid Approach
The Spanish Data Bank PEGASO M. Martínez-Sellés
Pathophysiology BMS 243 Rheumatic Heart Disease
TAVI Passed the Exam and is Ready for Clinical Use in Inoperable Patients Disclosures Research Funding and Speaking Honoraria: Edwards Lifesciences.
Circulatory Diseases.
Early Outcomes with the Evolut R Repositionable Self-Expanding Transcatheter Aortic Valve in the United States Mathew Williams, MD, For the Evolut R US.
University of Pennsylvania
Giuseppe Tarantini MD, PhD
Early Recovery of Left Ventricular Systolic Function After CoreValve Transcatheter Aortic Valve Replacement Harold L. Dauerman, MD; Michael J. Reardon,
Management strategy for patients with aortic stenosis
Treatment of acute renal failure
Updates From SURTAVI in Intermediate Risk Patients
Niv Ad, MD Chief, Cardiac Surgery Professor of Surgery, VCU
CoreValve Continued Access Study Shows Continued Improvement in 1-Year Outcomes With Self-Expanding Transcatheter Aortic Valve Replacement Steven J. Yakubov,
Incidence of and Risk Factors for Neurological Complications of Cardiac Bypass Surgery in Children with Congenital Heart Disease Dr Neeraj Bhangu, Dr John.
15th November 2017 James Holmes
Six-month–adjusted survival after aortic valve replacement (AVR) for severe aortic stenosis (AS) stratified by procedure and preoperative ejection fraction.
by Mario Gössl, Garvan C. Kane, William Mauermann, and David R. Holmes
Risk Stratification of Severe, Symptomatic Aortic Stenosis Patients
Late Follow-Up from the PARTNER Aortic Valve-in-Valve Registry
Cardiovacular Research Technologies
Chapter 1 Benefits and Risks Associated with Physical Activity
Samir R. Kapadia, MD On behalf of The PARTNER Trial Investigators
Update in Cardiac and Thoracic Surgery
Morbidity of Bleeding After Cardiac Surgery: Is It Blood Transfusion, Reoperation for Bleeding, or Both?  Alessandro Vivacqua, MD, Colleen G. Koch, MD,
Trends in Acute Kidney Injury, Associated Use of Dialysis, and Mortality After Cardiac Surgery, 1999 to 2008  Colin R. Lenihan, MBBCh, BAO, Maria E. Montez-Rath,
Best Heart Surgeon In India Million of surgeries are done each year to correct heart problems among children and adults. Although there are more than a.
A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned  Robert E.
Treatment of acute renal failure
Thomas A. Treibel et al. JACC 2018;71:
Understanding the Heart
Presentation transcript:

Applying Classification of Recommendation and Level of Evidence

Activity, Exercise Prescription & Cardiac Rehab Recommendations Class I Exercise training (or regular physical activity) is recommended as safe and effective for pts w/ HF who are able to participate to improve functional status Level of Evidence A Class IIa Cardiac rehab can be useful in clinically stable pts w/ HF to improve functional capacity, exercise duration, HRQOL and mortality Level of Evidence B

An Under-diagnosed and Under-treated Disease Studies show at least 40% of SAS patients are not treated with an AVR11-17 Studies show at least 40% of severe aortic stenosis (SAS) patients are not treated with an AVR11-17

What Causes Aortic Stenosis in Adults Less Common More Common Congenital Abnormality Rheumatic Fever Age-Related Calcific Aortic Stenosis Aortic valve stenosis — or aortic stenosis — occurs when the heart's aortic valve narrows. This narrowing prevents the valve from opening fully, which obstructs blood flow from your heart into your aorta and onward to the rest of his / her body.  Usually when aortic valve stenosis becomes severe and symptomatic, per ACC/AHA guidelines, the native valve should be replaced. Left untreated, aortic valve stenosis may lead to sudden death. Images courtesy of John Webb, MD at St. Paul’s Hospital and Renu Virmani, MD at the CVPath Institute

Traditional AS Therapy Medical therapy does not reverse or halt AS progression Balloon Valvuloplasty (BAV) Surgical AV Replacement (SAVR) Surgical approach varies Midline sternotomy Minimally invasive

Characteristics of Traditional Surgical Therapies CardioPulmonary Bypass Pump (CPB) Cross Clamping of Aorta Cerebrovascular Accident (CVA) Bleeding Wound Healing Mobility Fluid Shifts Prolonged Intubation Arrthymia Prolonged Anesthesia Post-operative Permanent Pacemaker (PPM)

In-operable? aka ‘High Risk,’ ‘Prohibitive Risk,’ ‘Extreme Risk’ STS Risk Score > 8% - notes age, sex, BMI, pulmonary disease, coronary disease, renal disease, NYHA STS Mortality Risk > 15% (risk of dying intra-operatively or post-operatively within 30 days) LVEF < 35% Frailty 5 meter gait 6 minute walk Katz Index ADL Independence Edmonton Frail Scale Grip Strength Albumin Level KCCQ-12 Co-morbids Pulmonary HTN Undergoing Cancer Treatment Poorly controlled diabetes Hospitalizations Nutrition Mobility Sniff Test